TNF and rheumatoid arthritis: Among the 50 female RA patients receiving their first TNF-α inhibitors, 31 patients (62%) continued with the first inhibitor for 15 months, while 19 (38%) completely discontinued their use and were excluded from our analysis (Figure 2).